Design and synthesis of a novel series of [1-(4-hydroxy-benzyl)-1H-indol-5-yloxy]-acetic acid compounds as potent, selective, thyroid hormone receptor β agonists

被引:7
作者
Burkholder, Timothy P. [1 ]
Cunningham, Brian E. [1 ]
Clayton, Joshua R. [1 ]
Lander, Peter A. [1 ]
Brown, Matthew L. [1 ]
Doti, Robert A. [1 ]
Durst, Gregory L. [1 ]
Montrose-Rafizadeh, Chahrzad [2 ]
King, Constance [2 ]
Osborne, Harold E. [2 ]
Amos, Robert M. [2 ]
Zink, Richard W. [2 ]
Stramm, Lawrence E. [2 ]
Burris, Thomas P. [3 ]
Cardona, Guemalli [3 ]
Konkol, Debra L. [4 ]
Reidy, Charles [4 ]
Christe, Michael E. [4 ]
Genin, Michael J. [1 ]
机构
[1] Lilly Corp Ctr, Div Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA
[2] Lilly Corp Ctr, Div Eli Lilly & Co, Lilly Res Labs, Lead Optimizat Biol, Indianapolis, IN 46285 USA
[3] Lilly Corp Ctr, Div Eli Lilly & Co, Lilly Res Labs, Bone & Inflammat Therapeut Area, Indianapolis, IN 46285 USA
[4] Lilly Corp Ctr, Div Eli Lilly & Co, Lilly Res Labs, Diabet Therapeut Area, Indianapolis, IN 46285 USA
关键词
Thyroid hormone; Agonist; TR-beta; Indole; THYROMIMETICS; LIGANDS; DISEASE; SYSTEM;
D O I
10.1016/j.bmcl.2015.02.062
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The design, synthesis, and structure activity relationships for a novel series of indoles as potent, selective, thyroid hormone receptor beta (TR beta) agonists is described. Compounds with >50 x binding selectivity for TRb over TR alpha were generated and evaluation of compound 1c from this series in a model of dyslipidemia demonstrated positive effects on plasma lipid endpoints in vivo. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1377 / 1380
页数:4
相关论文
共 22 条
[1]  
Blange I, 1997, BIOL PHARM BULL, V20, P1123
[2]   Ligand selectivity by seeking hydrophobicity in thyroid hormone receptor [J].
Borngraeber, S ;
Budny, MJ ;
Chiellini, G ;
Cunha-Lima, ST ;
Togashi, M ;
Webb, P ;
Baxter, JD ;
Scanlan, TS ;
Fletterick, RJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (26) :15358-15363
[3]   REGIOSELECTIVITY OF ELECTROPHILIC AROMATIC-SUBSTITUTION - SYNTHESES OF 6-SULFAMOYLINDOLINES AND 7-SULFAMOYLINDOLINES AND SULPAMOYLINDOLES [J].
BORROR, AL ;
CHINOPOROS, E ;
FILOSA, MP ;
HERCHEN, SR ;
PETERSEN, CP ;
STERN, CA .
JOURNAL OF ORGANIC CHEMISTRY, 1988, 53 (09) :2047-2052
[4]   PROTECTION OF HYDROXYL GROUPS AS TERT-BUTYLDIMETHYLSILYL DERIVATIVES [J].
COREY, EJ ;
VENKATESWARLU, A .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1972, 94 (17) :6190-+
[5]  
Corriu R.J. P., 1972, J. Chem. Soc. Chem. Commun, P144
[6]   Structure and specificity of nuclear receptor-coactivator interactions [J].
Darimont, BD ;
Wagner, RL ;
Apriletti, JW ;
Stallcup, MR ;
Kushner, PJ ;
Baxter, JD ;
Fletterick, RJ ;
Yamamoto, KR .
GENES & DEVELOPMENT, 1998, 12 (21) :3343-3356
[7]   THYROXINE ANALOGS .23. QUANTITATIVE STRUCTURE-ACTIVITY CORRELATION STUDIES OF INVIVO AND INVITRO THYROMIMETIC ACTIVITIES [J].
DIETRICH, SW ;
BOLGER, MB ;
KOLLMAN, PA ;
JORGENSEN, EC .
JOURNAL OF MEDICINAL CHEMISTRY, 1977, 20 (07) :863-880
[8]   Indole inhibitors of human nonpancreatic secretory phospholipase A(2) .2. Indole-3-acetamides with additional functionality [J].
Dillard, RD ;
Bach, NJ ;
Draheim, SE ;
Berry, DR ;
Carlson, DG ;
Chirgadze, NY ;
Clawson, DK ;
Hartley, LW ;
Johnson, LM ;
Jones, ND ;
McKinney, ER ;
Mihelich, ED ;
Olkowski, JL ;
Schevitz, RW ;
Smith, AC ;
Snyder, DW ;
Sommers, CD ;
Wery, JP .
JOURNAL OF MEDICINAL CHEMISTRY, 1996, 39 (26) :5137-5158
[9]   Discovery of a novel series of 6-azauracil-based thyroid hormone receptor ligands:: Potent, TRβ subtype-selective thyromimetics [J].
Dow, RL ;
Schneider, SR ;
Paight, ES ;
Hank, RF ;
Chiang, P ;
Cornelius, P ;
Lee, E ;
Newsome, WP ;
Swick, AG ;
Spitzer, J ;
Hargrove, DM ;
Patterson, TA ;
Pandit, J ;
Chrunyk, BA ;
LeMotte, PK ;
Danley, DE ;
Rosner, MH ;
Ammirati, MJ ;
Simons, SP ;
Schulte, GK ;
Tate, BF ;
DaSilva-Jardine, P .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2003, 13 (03) :379-382
[10]  
FORREST D, 1994, SEMIN CANCER BIOL, V5, P167